Evidence map›Paper›PMID 29976855›Full record

ArticleSensors (Basel, Switzerland)2018

Targeting FRET-Based Reporters for cAMP and PKA Activity Using AKAP79.

Nshunge Musheshe, Miguel J Lobo, Martina Schmidt, Manuela Zaccolo

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Activation of IPAmerican journal of physiology. Heart and circulatory physiology · 2024
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Sensing Senses: Optical Biosensors to Study Gustation.Sensors (Basel, Switzerland) · 2020
    Review
  7. Review
  8. Article
  9. Imaging cAMP nanodomains in the heart.Biochemical Society transactions · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nshunge MushesheDepartment of Molecular Pharmacology, University of Groningen, PO Box 72, 9700 AB Groningen, The Netherlands. nshunge.musheshe@dpag.ox.ac.uk.
Miguel J LoboDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 2JD, UK. miguel.lobo@dpag.ox.ac.uk.
Martina SchmidtDepartment of Molecular Pharmacology, University of Groningen, PO Box 72, 9700 AB Groningen, The Netherlands. m.schmidt@rug.nl.ORCID 0000-0003-3075-0630
Manuela ZaccoloDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 2JD, UK. manuela.zaccolo@dpag.ox.ac.uk.ORCID 0000-0002-0934-3662
University of Oxford · GBUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

British Heart Foundation PG/10/75/28537British Heart Foundation PG/15/5/31110British Heart Foundation RG/17/6/32944
6 · The paper itself

Abstract

Fluorescence resonance energy transfer (FRET)-based sensors for 3′⁻5′cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) allow real-time imaging of cAMP levels and kinase activity in intact cells with high spatiotemporal resolution. The development of FRET-based sensors has made it possible to directly demonstrate that cAMP and PKA signals are compartmentalized. These sensors are currently widely used to dissect the organization and physiological function of local cAMP/PKA signaling events in a variety of cell systems. Fusion to targeting domains has been used to direct the sensors to a specific subcellular nanodomain and to monitor cAMP and PKA activity at specific subcellular sites. Here, we investigate the effects of using the A-kinase anchoring protein 79 (AKAP79) as a targeting domain for cAMP and PKA FRET-based reporters. As AKAP79 interacts with PKA itself, when used as a targeting domain, it can potentially impact on the amplitude and kinetics of the signals recorded locally. By using as the targeting domain wild type AKAP79 or a mutant that cannot interact with PKA, we establish that AKAP79 does not affect the amplitude and kinetics of cAMP changes or the level of PKA activity detected by the sensor.

Indexed as

A Kinase Anchor ProteinsAnimalsCells, CulturedCyclic AMPCyclic AMP-Dependent Protein KinasesFluorescence Resonance Energy TransferMyocytes, CardiacPhosphorylationRatsRats, Sprague-DawleySignal TransductionA Kinase Anchor ProteinsCyclic AMPCyclic AMP-Dependent Protein Kinasesadrenergic signalingAKAP79cAMPfluorescence resonance energy transfer (FRET)phosphatasesprotein kinase A (PKA)real-time imaging

Identifiers

PMID29976855
PMCPMC6068576
OpenAlexW2866576095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.